IF you’re looking for a way to lose weight without pricey fat jabs, a supplement costing just 80p a day could be the way ...

Counterfeit forms of weight loss and diabetes drugs are endangering consumers, and Oklahoma General Attorney Gentner Drummond wants to take action against what he calls "bad actors" in the ...

But after her first injection of the jab Mounjaro on March 14 she began to get a headache and feel dizzy. Three days later on March 17, she woke up at 5am with “excruciating” stomach pains ...

Doctors wrote more than 660,000 prescriptions for Wegovy, Mounjaro and similar drugs for Minnesotans last year, according to insurance claims data from PurpleLab.

Vumerity comes as a delayed-release oral capsule. Vumerity contains the active ... factors including your insurance coverage and the pharmacy you use. If you have questions about how to pay ...

Senator John Fetterman admitted to using weight loss drug Mounjaro and has issued a plea about the 'game changer' medication. Fetterman, a democrat from Pennsylvania, said this week that he ...

The Indian launch of Mounjaro, or tirzepatide, by Eli Lilly last month marks a strategic inflection ... What used to be a matter of willpower and diet fads is increasingly being handled at the ...

Mounjaro, a new treatment for Type 2 diabetes and obesity, has been launched in India after CDSCO approval. The drug, developed by Eli Lilly and Company, targets both GIP and GLP-1 receptors ...

U.S. Sen. John Fetterman says there is a drug on the market that has changed his life: Mounjaro. The drug, generally prescribed for Type 2 diabetes and weight loss, has also been touted for its ...

Senator John Fetterman revealed Tuesday in a piece he penned in The New York Times that he has been using the popular weight loss drug, Mounjaro. He wrote that the drug helped him “feel like ...

Novo Nordisk’s India launch comes amid growing demand for glucagon-like peptide-1 (GLP-1)-based therapies, and follows the recent rollout of Mounjaro by Eli Lilly, a dual GLP-1/glucose-dependent ...

India’s obesity crisis fuels a $2.6 bn drug race as pharma firms rush to launch affordable semaglutide generics, aiming to transform access to weight-loss treatment.